Potential for functional redundancy in EGF and TGFα signaling in desmoid cells: a cDNA microarray analysis

References

• Alwan HA, van Zoelen EJ, van Leeuwen JE. 2003. Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome dependent EGFR de-ubiquitination. J Biol Chem. 278:35781–35790.
   PubMedGoogle Scholar
• Appleford PJ, Griffiths M, Yao SY, Ng AM, Chomey EG, Isaac RE, Coates D, Hope IA, Cass CE, Young JD, Baldwin SA. 2004. Functional redundancy of two nucleoside transporters of the ENT family (CeENT1, CeENT2) required for development of Caenorhabditis elegans. Mol Membr Biol. 21:247–259.
   PubMed Web of Science ®Google Scholar
• Arteaga CL. 2003. ErbB-targeted therapeutic approaches in human cancer. Exp Cell Res. 284:122–130.
   PubMed Web of Science ®Google Scholar
• Awwad R, Humphrey LE, Periyasamy B, Scovell WJr, Li W, Coleman K, Lynch M, Carboni J, Brattain MG, Howell GM. 1999. The EGF/TGFalpha response element within the TGFalpha promoter consists of a multi-complex regulatory element. Oncogene. 18:5923–5935.
   PubMedGoogle Scholar
• Barnard JA, Polk WH, Moses HL, Coffey RJ. 1991. Production of transforming growth factor-alpha by normal rat small intestine. Am J Physiol. 261:C994–C1000.
   Google Scholar
• Barnard JA, Graves-Deal R, Pittelkow MR, DuBois R, Cook P, Ramsey GW, Bishop PR, Damstrup L, Coffey RJ. 1994. Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family. J Biol Chem. 269:22817–22822.
   PubMed Web of Science ®Google Scholar
• Barral DC, Ramalho JS, Anders R, Hume AN, Knapton HJ, Tolmachova T, Collinson LM, Goulding D, Authi KS, Seabra MC. 2002. Functional redundancy of Rab27 proteins and the pathogenesis of Griscelli syndrome. J Clin Invest. 110:245–257.
   Google Scholar
• Beauchamp RD, Barnard JA, McCutchen CM, Cherner JA, Coffey RJJr. 1989. Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal. J Clin Invest. 84:1017–1023.
   PubMed Web of Science ®Google Scholar
• Bennet ST, Wilson AJ, Esposito L, Bouzekri N, Undlien DE, Cucca F, Nisticò L, Buzzetti R, Bosi E, Pociot F, Nerup J, Cambon-Thomsen A, Pugliese A, Shield JP, McKinney PA, Bain SC, Polychronakos C, Todd JA. 1997. Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele. The IMDIAB Group. Nat Genet. 17:350–352.
   PubMedGoogle Scholar
• Bonnerot C, Pintard L, Lutfalla G. 2003. Functional redundancy of Spb1p and a snR52-dependent mechanism for the 2′-O-ribose methylation of a conserved rRNA position in yeast. Mol Cell. 12:1309–1315.
   PubMedGoogle Scholar
• Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg ME. 2001. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol. 21:952–965.
   PubMed Web of Science ®Google Scholar
• Budanov AV, Karin M. 2008. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell. 134:451–460.
   PubMed Web of Science ®Google Scholar
• Bulut K, Felderbauer P, Hoeck K, Schmidt WE, Hoffmann P. 2008. Increased duodenal expression of transforming growth factor-alpha and epidermal growth factor during experimental colitis in rats. Eur J Gastroenterol Hepatol. 20:989–994.
   PubMed Web of Science ®Google Scholar
• Cadigan KM, Grossniklaus U, Gehring WJ. 1994. Functional redundancy: The respective roles of the two sloppy paired genes in Drosophila segmentation. Proc Natl Acad Sci USA. 91:6324–6328.
   PubMedGoogle Scholar
• Caffaro CE, Hirschberg CB, Berninsone PM. 2007. Functional redundancy between two Caenorhabditis elegans nucleotide sugar transporters with a novel transport mechanism. J Biol Chem. 282:27970–27975.
   PubMedGoogle Scholar
• Carev D, Saraga M, Saraga-Babic M. 2008. Expression of intermediate filaments, EGF and TGF-alpha in early human kidney development. J Mol Histol. 39:227–235.
   PubMedGoogle Scholar
• Chailler P, Brière N. 1998. Mitogenic effects of EGF/TGF alpha and immunolocalization of cognate receptors in human fetal kidneys. Biofactors. 7:323–335.
   PubMedGoogle Scholar
• Chandler VL, Stam M. 2004. Chromatin conversations: Mechanisms and implications of paramutation. Nat Rev Genet. 5:532–544.
   PubMed Web of Science ®Google Scholar
• Chokki M, Mitsuhashi H, Kamimura T. 2006. Metalloprotease-dependent amphiregulin release mediates tumor necrosis factor-alpha-induced IL-8 secretion in the human airway epithelial cell line NCI-H292. Life Sci. 78:3051–3057.
   PubMedGoogle Scholar
• Chou KC, Elrod DW. 2003. Prediction of enzyme family classes. J Proteome Res. 2:183–190.
   PubMedGoogle Scholar
• Cho S, Ko HM, Kim JM, Lee JA, Park JE, Jang MS, Park SG, Lee DH, Ryu SE, Park BC. 2004. Positive regulation of apoptosis signal-regulating kinase 1 by hD53L1. J Biol Chem. 279:16050–16056.
   PubMedGoogle Scholar
• Citri A, Yarden Y. 2006. EGF-ERBB signalling: Towards the systems level. Nat Rev Mol Cell Biol. 7:505–516.
   PubMed Web of Science ®Google Scholar
• Cui X, Kim HJ, Kuiatse I, Kim H, Brown PH, Lee AV. 2006. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration. Cancer Res. 66:5304–5313.
   PubMedGoogle Scholar
• Doble BW, Patel S, Wood GA, Kockeritz LK, Woodgett JR. 2007. Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev Cell. 12:957–971.
   PubMed Web of Science ®Google Scholar
• Dorweiler JE, Carey CC, Kubo KM, Hollick JB, Kermicle JL, Chandler VL. 2000. Mediator of paramutation1 is required for establishment and maintenance of paramutation at multiple maize loci. Plant Cell. 12:2101–2118.
   PubMed Web of Science ®Google Scholar
• Ellis IR, Schor AM, Schor SL. 2007. EGF AND TGF-alpha motogenic activities are mediated by the EGF receptor via distinct matrix-dependent mechanisms. Exp Cell Res. 313:732–741.
   PubMed Web of Science ®Google Scholar
• Ferenc T, Sygut J, Kopczyński J, Mayer M, Latos-Bieleńska A, Dziki A, Kulig A. 2006. Aggressive fibromatosis (desmoid tumors): Definition, occurrence, pathology, diagnostic problems, clinical behavior, genetic background. Pol J Pathol. 57:5–15.
   PubMedGoogle Scholar
• Fernandes H, Cohen S, Bishayee S. 2001. Glycosylation-induced conformational modification positively regulates receptor-receptor association: A study with an aberrant epidermal growth factor receptor (EGFRvIII/DeltaEGFR) expressed in cancer cells. J Biol Chem. 276:5375–5385.
   PubMed Web of Science ®Google Scholar
• French AR, Tadaki DK, Niyogi SK, Lauffenburger DA. 1995. Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction. J Biol Chem. 270:4334–4340.
   PubMed Web of Science ®Google Scholar
• Gibson S, Tu S, Oyer R, Anderson SM, Johnson GL. 1999. Epidermal growth factor protects epithelial cells against Fas-induced apoptosis. Requirement for Akt activation. J Biol Chem. 274:17612–17618.
   PubMed Web of Science ®Google Scholar
• Hebert C, Norris K, Scheper MA, Nikitakis N, Sauk JJ. 2007. High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer. 6:5.
   PubMed Web of Science ®Google Scholar
• Ho R, Minturn JE, Hishiki T, Zhao H, Wang Q, Cnaan A, Maris J, Evans AE, Brodeur GM. 2004. Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor. Cancer Res. 65:9868–9875.
   Google Scholar
• Hyatt DC, Ceresa BP. 2008. Cellular localization of the activated EGFR determines its effect on cell growth in MDA-MB-468 cells. Exp Cell Res. 314:3415–3425.
   PubMedGoogle Scholar
• Högnason T, Chatterjee S, Vartanian T, Ratan RR, Ernewein KM, Habib AA. 2001. Epidermal growth factor receptor induced apoptosis: Potentiation by inhibition of Ras signaling. FEBS Lett. 491:9–15.
   PubMedGoogle Scholar
• Ihmels J, Collins SR, Schuldiner M, Krogan NJ, Weissman JS. 2007. Backup without redundancy: Genetic interactions reveal the cost of duplicate gene loss. Mol Syst Biol. 3:86.
   PubMed Web of Science ®Google Scholar
• Jarriault S, Greenwald I. 2005. Evidence for functional redundancy between C. elegans ADAM proteins SUP-17/Kuzbanian and ADM-4/TACE. Dev Biol. 287:1–10.
   PubMedGoogle Scholar
• Joyner DE, Damron TA, Aboulafia A, Bokor W, Bastar JD, Randall RL. 2006. Heterogeneous expression of melanoma antigen (hMAGE) mRNA in mesenchymal neoplasia. Tissue Antigens. 68:19–27.
   PubMedGoogle Scholar
• Joyner DE, Trang SH, Damron TA, Aboulafia AJ, Cummings JE, Randall RL. 2009. Desmoid cell motility is induced in vitro by rhEGF. J Orthop Res. 27:1258–1262.
   PubMedGoogle Scholar
• Kawanishi H, Matsui Y, Ito M, Watanabe J, Takahashi T, Nishizawa K, Nishiyama H, Kamoto T, Mikami Y, Tanaka Y, Jung G, Akiyama H, Nobumasa H, Guilford P, Reeve A, Okuno Y, Tsujimoto G, Nakamura E, Ogawa O. 2008. Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer. Clin Cancer Res. 14:2579–2587.
   PubMed Web of Science ®Google Scholar
• Kim H, Rafiuddin-Shah M, Tu HC, Jeffers JR, Zambetti GP, Hsieh JJ, Cheng EH. 2006. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol. 8:1317–1319.
   PubMedGoogle Scholar
• Kopnin PB, Agapova LS, Kopnin BP, Chumakov PM. 2007. Repression of sestrin family genes contributes to oncogenic Ras-induced reactive oxygen species up regulation and genetic instability. Cancer Res. 67:4671–4678.
   PubMedGoogle Scholar
• Kotiligam D, Lazar AJ, Pollock RE, Lev D. 2008. Desmoid tumor: A disease opportune for molecular insights. Histol Histopathol. 23:117–126.
   PubMed Web of Science ®Google Scholar
• Krakauer DC, Plotkin JB. 2002. Redundancy, antiredundancy, and the robustness of genomes. Proc Natl Acad Sci USA. 99:1405–1409.
   PubMedGoogle Scholar
• Krüger M, Schmid T, Krüger S, Bober E, Braun T. 2006. Functional redundancy of NSCL-1 and NeuroD during development of the petrosal and vestibulocochlear ganglia. Eur J Neurosci. 24:1581–1590.
   PubMedGoogle Scholar
• Ladd AN, Charlet N, Cooper TA. 2001. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol Cell Biol. 21:1285–1296.
   PubMed Web of Science ®Google Scholar
• Lenferink AE, De Roos AD, Van Vugt MJ, Van de Poll ML, Van Zoelen EJ. 1998. The linear C-terminal regions of epidermal growth factor (EGF) and transforming growth factor-alpha bind to different epitopes on the human EGF receptor. Biochem J. 336:147–151.
   PubMedGoogle Scholar
• Liu HX, Henson BS, Zhou Y, D'Silva NJ, Mistretta CM. 2008. Fungiform papilla pattern: EGF regulates inter-papilla lingual epithelium and decreases papilla number by means of PI3K/Akt, MEK/ERK, and p38 MAPK signaling. Dev Dyn. 237:2378–2393.
   PubMedGoogle Scholar
• Lund-Johansen M, Bjerkvig R, Humphrey PA, Bigner SH, Bigner DD, Laerum OD. 1990. Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. Cancer Res. 50:6039–6044.
   PubMed Web of Science ®Google Scholar
• Lysiak JJ, Han VK, Lala PK. 1993. Localization of transforming growth factor alpha in the human placenta and decidua: Role in trophoblast growth. Biol Reprod. 49:885–894.
   PubMed Web of Science ®Google Scholar
• Mills BG, Frausto A, Brien E. 2000. Cytokines associated with the pathophysiology of aggressive fibromatosis. J Orthop Res. 18:655–662.
   PubMedGoogle Scholar
• Muzio M, Salvesen GS, Dixit VM. 1997. FLICE induced apoptosis in a cell free system. Cleavage of caspase zymogens. J Biol Chem. 272:2952–2956.
   PubMed Web of Science ®Google Scholar
• Nobuta K, Lu C, Shrivastava R, Pillay M, De Paoli E, Accerbi M, Arteaga Vazquez M, Sidorenko, Jeong DH, Yen Y, Green PJ, Chandler VL, Meyers BC. 2008. Distinct size distribution of endogeneous siRNAs in maize: Evidence from deep sequencing in the mop1-1 mutant. Proc Natl Acad Sci USA. 105:14958–14963.
   PubMed Web of Science ®Google Scholar
• Nowak MA, Boerlijst MC, Cooke J, Smith JM. 1997. Evolution of genetic redundancy. Nature. 388:167–171.
   PubMed Web of Science ®Google Scholar
• Oliver BL, Sha'afi RI, Hajjar JJ. 1995. Transforming growth factor-alpha and epidermal growth factor activate mitogen-activated protein kinase and its substrates in intestinal epithelial cells. Proc Soc Exp Biol Med. 210:162–170.
   PubMedGoogle Scholar
• Otter I, Conus S, Ravn U, Rager M, Olivier R, Monney L, Fabbro D, Borner C. 1998. The binding properties and biological activities of Bcl-2 and Bax in cells exposed to apoptotic stimuli. J Biol Chem. 273:6110–6120.
   PubMed Web of Science ®Google Scholar
• Ouyang X, Gulliford T, Huang G, Epstein RJ. 1999. Transforming growth factor-alpha short-circuits downregulation of the epidermal growth factor receptor. J Cell Physiol. 179:52–57.
   PubMedGoogle Scholar
• Pastore S, Mascia F, Mariani V, Girolomoni G. 2008. The epidermal growth factor receptor system in skin repair and inflammation. J Invest Dermatol. 128:1365–1374.
   PubMed Web of Science ®Google Scholar
• Powell JAJr, Mousa SA. 2007. Neutrophil-activating protein-2- and interleukin 8-mediated angiogenesis. J Cell Biochem. 102:412–420.
   PubMed Web of Science ®Google Scholar
• Putz T, Culig Z, Eder IE, Nessler-Menardi C, Bartsch G, Grunicke H, Uberall F, Klocker H. 1999. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines. Cancer Res. 59:227–233.
   PubMed Web of Science ®Google Scholar
• Rassoulzadegan M, Grandjean V, Gounon P, Vincent S, Gillot I, Cuzin F. 2006. RNA-mediated non-mendelian inheritance of an epigenetic change in the mouse. Nature. 441:469–474.
   PubMed Web of Science ®Google Scholar
• Reddy CC, Wells A, Lauffenburger DA. 1996. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha. J Cell Physiol. 166:512–522.
   PubMedGoogle Scholar
• Reddy CC, Wells A, Lauffenburger DA. 1998. Comparative mitogenic potencies of EGF and TGF alpha and their dependence on receptor-limitation versus ligand-limitation. Med Biol Eng Comput. 36:499–507.
   PubMedGoogle Scholar
• Resat H, Ewald JA, Dixon DA, Wiley HS. 2003. An integrated model of epidermal growth factor receptor trafficking and signal transduction. Biophys J. 85:730–743.
   PubMed Web of Science ®Google Scholar
• Riese DJII, Stern DF. 1998. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays. 20:41–48.
   PubMed Web of Science ®Google Scholar
• Russell WE, Kaufmann WK, Sitaric S, Luetteke NC, Lee DC. 1996. Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice. Mol Carcinog. 15:183–189.
   PubMedGoogle Scholar
• Schneider MR, Wolf E. 2009. The epidermal growth factor receptor ligands at a glance. J Cell Physiol. 218:460–466.
   PubMed Web of Science ®Google Scholar
• Schultz G, Rotatori DS, Clark W. 1991. EGF and TGF-alpha in wound healing and repair. J Cell Biochem. 45:346–352.
   PubMed Web of Science ®Google Scholar
• Seth D, Shaw K, Jazayeri J, Leedman PJ. 1999. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells. Br J Cancer. 80:657–699.
   PubMedGoogle Scholar
• Sheng G, Guo J, Warner BW. 2007. Epidermal growth factor receptor signaling modulates apoptosis via p38alpha MAPK-dependent activation of Bax in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 293:G599–G606.
   Google Scholar
• Shilo BZ. 2005. Regulating the dynamics of EGF receptor signaling in space and time. Development. 132:4017–4027.
   PubMed Web of Science ®Google Scholar
• Siddiqui RA, Akard LP, Garcia JG, Cui Y, English D. 1999. Chemotactic migration triggers IL-8 generation in neutrophilic leukocytes. J Immunol. 162:1077–1083.
   PubMedGoogle Scholar
• Slavkin HC. 1993. Rieger syndrome revisited: Experimental approaches using pharmacologic and antisense strategies to abrogate EGF and TGF-alpha functions resulting in dysmorphogenesis during embryonic mouse craniofacial morphogenesis. Am J Med Genet. 47:689–697.
   PubMed Web of Science ®Google Scholar
• Svendsen CN, Skepper J, Rosser AE, ter Borg MG, Tyres P, Ryken T. 1997. Restricted growth potential of rat neural precursors as compared to mouse. Brain Res Dev Brain Res. 99:253–258.
   PubMedGoogle Scholar
• Tétreault MP, Chailler P, Beaulieu JF, Rivard N, Ménard D. 2008. Specific signaling cascades involved in cell spreading during healing of micro-wounded gastric epithelial monolayers. J Cell Biochem, Sep 18. [Epub ahead of print].
   PubMedGoogle Scholar
• Thoresen GH, Guren TK, Sandnes D, Peak M, Agius L, Christoffersen T. 1998. Response to transforming growth factor alpha (TGFalpha) and epidermal growth factor (EGF) in hepatocytes: Lower EGF receptor affinity of TGFalpha is associated with more sustained activation of p42/p44 mitogen-activated protein kinase and greater efficacy in stimulation of DNA synthesis. J Cell Physiol. 175:10–18.
   PubMed Web of Science ®Google Scholar
• Tsuchiya E, Matsuzaki G, Kurano K, Fukuchi T, Tsukao A, Miyakawa T. 1996. The Saccharomyces cerevisiae SSD1 gene is involved in the tolerance to high concentration of Ca2+ with the participation of HST1/NRC1/BFR1. Gene. 176:35–38.
   Google Scholar
• Veley KM, Michaels SD. 2008. Functional redundancy and new roles for genes of the autonomous floral-promotion pathway. Plant Physiol. 147:682–695.
   PubMedGoogle Scholar
• Wang D, Sai J, Carter G, Sachpatzidis A, Lolis E, Richmond A. 2002. PAK1 kinase is required for CXCL1-induced chemotaxis. Biochemistry. 41:7100–7107.
   PubMedGoogle Scholar
• Wang JG, Strong JA, Xie W, Yang RH, Coyle DE, Wick DM, Dorsey ED, Zhang JM. 2008. The chemokine CXCL1/growth related oncogene increases sodium currents and neuronal excitability in small diameter sensory neurons. Mol Pain. 4:38.
   PubMedGoogle Scholar
• Wang W, Edington HD, Jukic DM, Rao UN, Land SR, Kirkwood JM. 2008. Impact of IFNalpha2b upon pSTAT3 and the MEK/ERK MAPK pathway in melanoma. Cancer Immunol Immunother. 57:1315–1321.
   PubMedGoogle Scholar
• Webber EM, FitzGerald MJ, Brown PI, Bartlett MH, Fausto N. 1993. Transforming growth factor-alpha expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-alpha and hepatocyte growth factor. Hepatology. 18:1422–1431.
   PubMedGoogle Scholar
• Wilson KJ, Gilmore JL, Foley J, Lemmon MA, Riese DJ2nd. 2009. Functional selectivity of EGF family peptide growth factors: Implications for cancer. Pharmacol Ther.. 122:1–8.
   PubMed Web of Science ®Google Scholar
• Wong RWC. 2003. Transgenic and knock-out mice for deciphering the roles of EGFR ligands. Cell Mol Life Sci. 60:113–118.
   PubMed Web of Science ®Google Scholar
• Wong WM, Playford RJ, Wright NA. 2000. Peptide gene expression in gastrointestinal mucosal ulceration: Ordered sequence or redundancy?. Gut. 46:286–292.
   PubMed Web of Science ®Google Scholar
• Xian CJ, Li L, Deng YS, Zhao SP, Zhou XF. 2001. Lack of effects of transforming growth factor-alpha gene knockout on peripheral nerve regeneration may result from compensatory mechanisms. Exp Neurol. 172:182–188.
   PubMedGoogle Scholar
• Xian CJ, Cool JC, Howarth GS, Read LC. 2002. Effects of TGF-alpha gene knockout on epithelial cell kinetics and repair of methotrexate-induced damage in mouse small intestine. J Cell Physiol. 191:105–115.
   PubMedGoogle Scholar
• Yanai I, Korbel JO, Boue S, McWeeney SK, Bork P, Lercher MJ. 2006. Similar gene expression profiles do not imply similar tissue functions. Trends Genet. 22:132–138.
   PubMedGoogle Scholar
• Ying WZ, Zhang HG, Sanders PW. 2007. EGF receptor activity modulates apoptosis induced by inhibition of the proteasome of vascular smooth muscle cells. J Am Soc Nephrol. 18:131–142.
   PubMedGoogle Scholar
• Yi H, Sardesai N, Fujinuma T, Chan CW, Veena Gelvin SB. 2006. Constitutive expression exposes functional redundancy between the Arabidopsis histone H2A gene HTA1 and other H2A gene family members. Plant Cell. 18:1575–1589.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Kyo E, Tsuda T, Tsujino T, Ito M, Niimoto M, Tahara E. 1990. EGF and TGF-alpha, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors. Int J Cancer. 45:131–135.
   PubMed Web of Science ®Google Scholar
• Yoshimoto Y, Imoto M. 2002. Induction of EGF-dependent apoptosis by vacuolar-type H(+)-ATPase inhibitors in A431 cells overexpressing the EGF receptor. Exp Cell Res. 279:118–127.
   PubMedGoogle Scholar
• Yuan A, Chen JJ, Yao PL, Yang PC. 2005. The role of interleukin-8 in cancer cells and microenvironment interaction. Front Biosci. 10:853–865.
   PubMed Web of Science ®Google Scholar
• Yu C, Hale J, Ritchie K, Prasad NK, Irudayaraj J. 2009. Receptor overexpression or inhibition alters cell surface dynamics of EGF-EGFR interaction: New insights from real-time single molecule analysis. Biochem Biophys Res Commun. 378:376–382.
   PubMedGoogle Scholar
• Zhang P, Wong C, DePinho RA, Harper JW, Elledge SJ. 1998. Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development. Genes Dev. 12:3162–3167.
   PubMed Web of Science ®Google Scholar
• Zhong L, Roybal J, Chaerkady R, Zhang W, Choi K, Alvarez CA, Tran H, Creighton CJ, Yan S, Strieter RM, Pandey A, Kurie JM. 2008. Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment. Cancer Res. 68:7237–7245.
   PubMed Web of Science ®Google Scholar
• Zhou C, Qiu L, Sun Y, Healey S, Wanebo H, Kouttab N, Di W, Yan B, Wan Y. 2006. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells. Int J Oncol. 29:269–278.
   PubMed Web of Science ®Google Scholar
• Zhu HJ, Iaria J, Orchard S, Walker F, Burgess AW. 2003. Epidermal growth factor receptor: Association of extracellular domain negatively regulates intracellular kinase activation in the absence of ligand. Growth Factors. 21:15–30.
   PubMed Web of Science ®Google Scholar
• Zhu YM, Webster SJ, Flower D, Woll PJ. 2004. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells. Br J Cancer. 91:1970–1976.
   PubMed Web of Science ®Google Scholar